4
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Prognostic Factors in Nodular Transitional Cell Bladder Tumours

, , , , &
Pages 205-210 | Received 28 Nov 1991, Accepted 18 Jul 1992, Published online: 15 Feb 2010

REFERENCES

  • AaltomaaS, LipponenP, EskelinenM, KosmaV-M, MarinS, AlhavaE, SyrjänenK. Prognostic scores combining clinical, histological and morphometric variables in assessment of the disease outcome in female breast cancer. Int J Cancer 1991; 49: 886–892.
  • BaakJPA, OortJ. Manual of morphometry in diagnostic pathology. Berlin: Springer-Verlag, 1983.
  • BlomjousCEM, SchipperNW, BaakJPA, deVoogt HJ, McijerCJLM. Comparison of quantitative and classic prognosticators in urinary bladder carcinoma. Virchows Arch (A) 1989; 415: 421–428.
  • CarbinB-E, EkmanP, GustafsonH, ChristensenNJ, SilfveswärdC, SandstedtB. Grading of human urothelial carcinoma based on nuclear atypia and mitotic frequency. II. Prognostic importance. J Urol 1991; 145: 972–976.
  • ChauhanSS, GoldsteinLJ, GottesmanMM. Expression of cathepsin L in human tumours. Cancer Res 1991; 51: 1478–1481.
  • CollanY. General principles in grading lesions in quantitative histopathology. Path Res Pract 1989; 185: 539–543.
  • CoxDR. Regression models and life tables with discussion. JR Stat Soc B 1972; 34: 187–192.
  • EskelinenM, LipponenP, MarinS, HaapasaloH, MäkinenK, AhtolaH, PuittinenJ, NuutinenP, AlhavaE. Prognostic factors in human pancreatic cancer with special reference to quantitative histology. Scand J Gastroenterol 1991; 26: 483–490.
  • HaapasaloH, CollanY, AtkinNB, SeppäA. Prognosis of ovarian carcinomas: prediction by histoquantitative methods. Histopathology 1989; 15: 167–178.
  • HaapasaloH, CollanY, PesonenE. Volume corrected mitotic index (M/V index)—the standard of mitotic activity in neoplasms. Pathol Res Pract 1989; 185: 551–554.
  • HelanderK, HoferPA, HolmbergG. Karyometric investigations on urinary bladder carcinoma correlated to histopathological grading. Virchows Arch (A) 1984; 403: 117–125.
  • HerrHW, LaudoneVP, WhitmoreWF. An overview of intravesical therapy for superficial bladder tumors. J Urol 1987; 138: 1363–1368.
  • JauhiainenK. Intravesical chemotherapy of superficial urinary bladder cancer. Thesis. Helsinki: Helsinki University Press, 1986.
  • LeeE, DesuM. A computer program for comparing k samples with right censored data. Computer Program in Biomedicine 1972; 2: 315–318.
  • LipponenPK, EskelinenMJ. Volume corrected mitotic index (M/V index) and mitotic activity index (MAI) in transitional cell bladder cancer. Eur Urol 1990; 18: 258–262.
  • LipponenP, EskelinenM, KivirantaJ, PesonenE. Prognosis of transitional cell bladder cancer: A multivariate prognostic score for improved prediction. J Urol 1991; 146: 1535–1540.
  • LipponenPK, EskelinenMJ, NordlingS. Relationship between DNA flow cytometric data, nuclear morphometric variables and volume corrected mitotic index in transitonal cell bladder tumours. Eur Urol 1991; 19: 327–331.
  • LipponenPK, EskelinenMJ, NordlingS. Progression and survival in transitonal cell bladder cancer: A comparison of established prognostic factors, S phase fraction and DNA ploidy. Eur J Cancer 1991; 27: 877–881.
  • LipponenPK, EskelinenMJ, NordlingS. Nucleolar organiser regions as prognostic factors in transitional cell bladder cancer. Br J Cancer 1991; 64: 1139–1144.
  • LipponenPK, EskelinenMJ, SotarautaM. Prediction of T1–2 GI-II transitional cell bladder cancer; evaluation of the histoquantitative methods. Scand J Urol Nephrol 1991; 25: 129–134.
  • LipponenPK, KosmaV-M, CollanY, KuljuT, KosunenO, EskelinenM. Potential of nuclear morphometry and volume-corrected mitotic index in grading transitional cell carcinoma of the urinary bladder. Eur Urol 1990; 17: 333–337.
  • MalmströmPU, NorlenBJ, AnderssonB, BuschC. Combination of blood group ABH antigen status and DNA ploidy as independent prognostic factor in transitional cell carcinomas. Scand J Urol Nephrol 1989; 64: 49–55.
  • MostofiFK. International histological classification of tumours. In No 10 Histological typing of urinary bladder tumours. Geneva: WHO, 1973.
  • SchapersRFM, PauwelsRPE, HavenithMG, SmeetsWGB, vanden Brandt PA, BosmanFT. Prognostic significance of type IV collagen and laminin immunoreactivity in urothelial carcinomas of the bladder. Cancer 1990; 66: 2583–2588.
  • TsujihashiH, NakanishiA, MatsudaH, UejimaS, KuritaT. Cell proliferation of human bladder tumors determined by BRDURD and Ki-67 immunostaining. J Urol 1991; 145: 846–849.
  • UICC. International Union Against Cancer. TNM classification of malignant tumours. Geneva: UICC, 1978.
  • ZinggEJ, WallaceDMA. Bladder cancer. Heidelberg: Springer-Verlag, 1985: 161–191.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.